Literature DB >> 23764425

Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers.

Daniel Hagerstrand1, Alexander Tong, Steven E Schumacher, Nina Ilic, Rhine R Shen, Hiu Wing Cheung, Francisca Vazquez, Yashaswi Shrestha, So Young Kim, Andrew O Giacomelli, Joseph Rosenbluh, Anna C Schinzel, Nicole A Spardy, David A Barbie, Craig H Mermel, Barbara A Weir, Levi A Garraway, Pablo Tamayo, Jill P Mesirov, Rameen Beroukhim, William C Hahn.   

Abstract

UNLABELLED: 3q26 is frequently amplified in several cancer types with a common amplified region containing 20 genes. To identify cancer driver genes in this region, we interrogated the function of each of these genes by loss- and gain-of-function genetic screens. Specifically, we found that TLOC1 (SEC62) was selectively required for the proliferation of cell lines with 3q26 amplification. Increased TLOC1 expression induced anchorage-independent growth, and a second 3q26 gene, SKIL (SNON), facilitated cell invasion in immortalized human mammary epithelial cells. Expression of both TLOC1 and SKIL induced subcutaneous tumor growth. Proteomic studies showed that TLOC1 binds to DDX3X, which is essential for TLOC1-induced transformation and affected protein translation. SKIL induced invasion through upregulation of SLUG (SNAI2) expression. Together, these studies identify TLOC1 and SKIL as driver genes at 3q26 and more broadly suggest that cooperating genes may be coamplified in other regions with somatic copy number gain. SIGNIFICANCE: These studies identify TLOC1 and SKIL as driver genes in 3q26. These observations provide evidence that regions of somatic copy number gain may harbor cooperating genes of different but complementary functions. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23764425      PMCID: PMC3770815          DOI: 10.1158/2159-8290.CD-12-0592

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  50 in total

Review 1.  Translational control in cancer.

Authors:  Deborah Silvera; Silvia C Formenti; Robert J Schneider
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

2.  Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes.

Authors:  Joseph H Taube; Jason I Herschkowitz; Kakajan Komurov; Alicia Y Zhou; Supriya Gupta; Jing Yang; Kimberly Hartwell; Tamer T Onder; Piyush B Gupta; Kurt W Evans; Brett G Hollier; Prahlad T Ram; Eric S Lander; Jeffrey M Rosen; Robert A Weinberg; Sendurai A Mani
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

3.  Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress.

Authors:  Zheming Lu; Lei Zhou; Patrick Killela; Ahmed B Rasheed; Chunhui Di; William E Poe; Roger E McLendon; Darell D Bigner; Christopher Nicchitta; Hai Yan
Journal:  Cancer Res       Date:  2009-11-17       Impact factor: 12.701

4.  Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.

Authors:  Haixia Cheng; Tsuyoshi Fukushima; Nobuyasu Takahashi; Hiroyuki Tanaka; Hiroaki Kataoka
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

5.  Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.

Authors:  Lars Zender; Mona S Spector; Wen Xue; Peer Flemming; Carlos Cordon-Cardo; John Silke; Sheung-Tat Fan; John M Luk; Michael Wigler; Gregory J Hannon; David Mu; Robert Lucito; Scott Powers; Scott W Lowe
Journal:  Cell       Date:  2006-06-30       Impact factor: 41.582

6.  Integrative genomics viewer.

Authors:  James T Robinson; Helga Thorvaldsdóttir; Wendy Winckler; Mitchell Guttman; Eric S Lander; Gad Getz; Jill P Mesirov
Journal:  Nat Biotechnol       Date:  2011-01       Impact factor: 54.908

7.  SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.

Authors:  Adam J Bass; Hideo Watanabe; Craig H Mermel; Soyoung Yu; Sven Perner; Roel G Verhaak; So Young Kim; Leslie Wardwell; Pablo Tamayo; Irit Gat-Viks; Alex H Ramos; Michele S Woo; Barbara A Weir; Gad Getz; Rameen Beroukhim; Michael O'Kelly; Amit Dutt; Orit Rozenblatt-Rosen; Piotr Dziunycz; Justin Komisarof; Lucian R Chirieac; Christopher J Lafargue; Veit Scheble; Theresia Wilbertz; Changqing Ma; Shilpa Rao; Hiroshi Nakagawa; Douglas B Stairs; Lin Lin; Thomas J Giordano; Patrick Wagner; John D Minna; Adi F Gazdar; Chang Qi Zhu; Marcia S Brose; Ivan Cecconello; Ulysses Ribeiro; Suely K Marie; Olav Dahl; Ramesh A Shivdasani; Ming-Sound Tsao; Mark A Rubin; Kwok K Wong; Aviv Regev; William C Hahn; David G Beer; Anil K Rustgi; Matthew Meyerson
Journal:  Nat Genet       Date:  2009-10-04       Impact factor: 38.330

8.  Evolutionary gain of function for the ER membrane protein Sec62 from yeast to humans.

Authors:  Linda Müller; Maria Diaz de Escauriaza; Patrick Lajoie; Melanie Theis; Martin Jung; Anika Müller; Carsten Burgard; Markus Greiner; Erik L Snapp; Johanna Dudek; Richard Zimmermann
Journal:  Mol Biol Cell       Date:  2010-01-13       Impact factor: 4.138

9.  The landscape of somatic copy-number alteration across human cancers.

Authors:  Rameen Beroukhim; Craig H Mermel; Dale Porter; Guo Wei; Soumya Raychaudhuri; Jerry Donovan; Jordi Barretina; Jesse S Boehm; Jennifer Dobson; Mitsuyoshi Urashima; Kevin T Mc Henry; Reid M Pinchback; Azra H Ligon; Yoon-Jae Cho; Leila Haery; Heidi Greulich; Michael Reich; Wendy Winckler; Michael S Lawrence; Barbara A Weir; Kumiko E Tanaka; Derek Y Chiang; Adam J Bass; Alice Loo; Carter Hoffman; John Prensner; Ted Liefeld; Qing Gao; Derek Yecies; Sabina Signoretti; Elizabeth Maher; Frederic J Kaye; Hidefumi Sasaki; Joel E Tepper; Jonathan A Fletcher; Josep Tabernero; José Baselga; Ming-Sound Tsao; Francesca Demichelis; Mark A Rubin; Pasi A Janne; Mark J Daly; Carmelo Nucera; Ross L Levine; Benjamin L Ebert; Stacey Gabriel; Anil K Rustgi; Cristina R Antonescu; Marc Ladanyi; Anthony Letai; Levi A Garraway; Massimo Loda; David G Beer; Lawrence D True; Aikou Okamoto; Scott L Pomeroy; Samuel Singer; Todd R Golub; Eric S Lander; Gad Getz; William R Sellers; Matthew Meyerson
Journal:  Nature       Date:  2010-02-18       Impact factor: 49.962

10.  Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency.

Authors:  Maria Barna; Aya Pusic; Ornella Zollo; Maria Costa; Nadya Kondrashov; Eduardo Rego; Pulivarthi H Rao; Davide Ruggero
Journal:  Nature       Date:  2008-11-16       Impact factor: 49.962

View more
  38 in total

1.  The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer.

Authors:  Leo Y Luo; Eejung Kim; Hiu Wing Cheung; Barbara A Weir; Gavin P Dunn; Rhine R Shen; William C Hahn
Journal:  Mol Cancer Res       Date:  2014-11-03       Impact factor: 5.852

2.  Role of SEC62 in ER maintenance: A link with ER stress tolerance in SEC62-overexpressing tumors?

Authors:  Timothy J Bergmann; Fiorenza Fumagalli; Marisa Loi; Maurizio Molinari
Journal:  Mol Cell Oncol       Date:  2017-01-26

3.  Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery.

Authors:  Fiorenza Fumagalli; Julia Noack; Timothy J Bergmann; Eduardo Cebollero; Giorgia Brambilla Pisoni; Elisa Fasana; Ilaria Fregno; Carmela Galli; Marisa Loi; Tatiana Soldà; Rocco D'Antuono; Andrea Raimondi; Martin Jung; Armin Melnyk; Stefan Schorr; Anne Schreiber; Luca Simonelli; Luca Varani; Caroline Wilson-Zbinden; Oliver Zerbe; Kay Hofmann; Matthias Peter; Manfredo Quadroni; Richard Zimmermann; Maurizio Molinari
Journal:  Nat Cell Biol       Date:  2016-10-17       Impact factor: 28.824

4.  The chromosome 3q26 OncCassette: A multigenic driver of human cancer.

Authors:  Alan P Fields; Verline Justilien; Nicole R Murray
Journal:  Adv Biol Regul       Date:  2015-12-23

Review 5.  Components and Mechanisms of Import, Modification, Folding, and Assembly of Immunoglobulins in the Endoplasmic Reticulum.

Authors:  Richard Zimmermann
Journal:  J Clin Immunol       Date:  2016-02-29       Impact factor: 8.317

6.  4th international conference on tumor progression and therapeutic resistance: meeting report.

Authors:  Varun V Prabhu; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 7.  The Dual Roles of the Atypical Protein Kinase Cs in Cancer.

Authors:  Miguel Reina-Campos; Maria T Diaz-Meco; Jorge Moscat
Journal:  Cancer Cell       Date:  2019-08-29       Impact factor: 31.743

8.  Minority stress and leukocyte gene expression in sexual minority men living with treated HIV infection.

Authors:  Annesa Flentje; Kord M Kober; Adam W Carrico; Torsten B Neilands; Elena Flowers; Nicholas C Heck; Bradley E Aouizerat
Journal:  Brain Behav Immun       Date:  2018-03-13       Impact factor: 7.217

Review 9.  Functional regulation of phospholipase D expression in cancer and inflammation.

Authors:  Dong Woo Kang; Kang-Yell Choi; Do Sik Min
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

10.  Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma.

Authors:  Shinichi Yachida; Laura D Wood; Masami Suzuki; Erina Takai; Yasushi Totoki; Mamoru Kato; Claudio Luchini; Yasuhito Arai; Hiromi Nakamura; Natsuko Hama; Asmaa Elzawahry; Fumie Hosoda; Tomoki Shirota; Nobuhiko Morimoto; Kunio Hori; Jun Funazaki; Hikaru Tanaka; Chigusa Morizane; Takuji Okusaka; Satoshi Nara; Kazuaki Shimada; Nobuyoshi Hiraoka; Hirokazu Taniguchi; Ryota Higuchi; Minoru Oshima; Keiichi Okano; Seiko Hirono; Masamichi Mizuma; Koji Arihiro; Masakazu Yamamoto; Michiaki Unno; Hiroki Yamaue; Matthew J Weiss; Christopher L Wolfgang; Toru Furukawa; Hitoshi Nakagama; Bert Vogelstein; Tohru Kiyono; Ralph H Hruban; Tatsuhiro Shibata
Journal:  Cancer Cell       Date:  2016-01-21       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.